Autoantibodies Against PFDN2 Are Associated With An Increased Risk of Type 2 Diabetes: A Case-Control Study

BACKGROUND: The adaptive immune system is involved in type 2 diabetes mellitus (T2DM), indicating the presence of unidentified autoantibodies that might be useful biomarkers for emerging immunomodulatory therapy. A prior microarray study with a small number of participants suggested the association...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes Metab Res Rev
Hauptverfasser: Chang, Douglas C., Piaggi, Paolo, Hanson, Robert L., Knowler, William C., Bogardus, Clifton, Krakoff, Jonathan
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6417877/
https://ncbi.nlm.nih.gov/pubmed/28731290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.2922
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge